Business · 27/06/2022
FDA Revokes Two COVID-19 Emergency Use Authorizations for Quanterix Corp.
The US Food and Drug Administration (FDA) has revoked two Emergency Use Authorizations (EUAs) for Quanterix Corp.'s COVID-19 diagnostic tests, citing reasons outlined in the revocation document.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →